MedTrace Logo

Evaluatıon of TREM-1, MMP-8 and TIMP-1 Levels in Perı-Implant Crevicular Fluıd of Perı-Implanted Indıvıduals

NCT07379892 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2026-02-09

No results posted yet for this study

Summary

The aim of this study was to evaluate the relationship between Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1), Matrix Metalloproteinases-8 (MMP-8) and Tissue Inhibitors of Metalloproteinases-1 (TIMP-1) levels in peri-implant crevicular fluid (PICF) in peri-implantitis patients.

Conditions

  • Periimplantitis

Interventions

OTHER

Collection of PICF samples

TREM-1, MMP-8 and TIPM-1 levels reseach in PICF samples

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2023-12-15
Completion
2024-05-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07379892 on ClinicalTrials.gov